Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rebecca A. Kaner is active.

Publication


Featured researches published by Rebecca A. Kaner.


Chemical Science | 2013

Metallohelices with activity against cisplatin-resistant cancer cells; does the mechanism involve DNA binding?

Viktor Brabec; Suzanne E. Howson; Rebecca A. Kaner; Rianne M. Lord; Jaroslav Malina; Roger M. Phillips; Qasem M. A. Abdallah; Patrick C. McGowan; Alison Rodger; Peter Scott

Enantiomers of a relatively rigid DNA-binding metallo-helix are shown to have comparable activity to that of cisplatin against the cell lines MCF7 (human breast adenocarcinoma) and A2780 (human ovarian carcinoma) but are ca five times more active against the cisplatin-resistant A2780cis. The cell-line HCT116 p53+/+ (human colon carcinoma) is highly sensitive giving IC50 values in the nM range, far lower than the cisplatin control. The hypothesis that the biological target of such metallohelices is DNA is probed by various techniques. Tertiary structure changes in ct-DNA (formation of loops and intramolecular coiling) on exposure to the compounds are demonstrated by atomic force microscopy and supported by circular/linear dichroism in solution. Selectivity for 5′-CACATA and 5′-CACTAT segments is shown by DNase I footprinting. Various three- and four-way oligonucleotide junctions are stabilised, and remarkably only the Λ metallo-helix enantiomer stabilizes T-shaped 3WJs during gel electrophoresis; this is despite the lack of a known helix binding site. In studies with oligonucleotide duplexes with bulges it is also shown for the first time that the metallo-helix binding strength and the number of binding sites are dependent on the size of the bulge. In contrast to all the above, flexible metallo-helices show little propensity for structured or selective DNA binding, and while for A2780 the cancer cell line cytotoxicity is retained the A2780cis strain shows significant resistance. For all compounds in the study, H2AX FACS assays on HCT116 p53+/+ showed that no significant DNA damage occurs. In contrast, cell cycle analysis shows that the DNA binders arrest cells in the G2/mitosis phase, and while all compounds cause apoptosis, the DNA binders have the greater effect. Taken together these screening and mechanistic results are consistent with the more rigid helices acting via a DNA binding mechanism while the flexible assemblies do not.


Dalton Transactions | 2013

Optically pure heterobimetallic helicates from self-assembly and click strategies

Suzanne E. Howson; Guy J. Clarkson; Alan D. Faulkner; Rebecca A. Kaner; Michael J. Whitmore; Peter Scott

Single diastereomer, diamagnetic, octahedral Fe(II) tris chelate complexes are synthesised that contain three pendant pyridine proligands pre-organised for coordination to a second metal. They bind Cu(I) and Ag(I) with coordination geometry depending on the identity of the metal and the detail of the ligand structure, but for example homohelical (ΔFe,ΔCu) configured systems with unusual trigonal planar Cu cations are formed exclusively in solution as shown by VT-NMR and supported by DFT calculations. Similar heterobimetallic tris(triazole) complexes are synthesised via clean CuAAC reactions at a tris(alkynyl) complex, although here the configurations of the two metals differ (ΔFe,ΛCu), leading to the first optically pure heterohelicates. A second series of Fe complexes perform less well in either strategy as a result of lack of preorganisation.


Nature Chemistry | 2014

Asymmetric triplex metallohelices with high and selective activity against cancer cells

Alan D. Faulkner; Rebecca A. Kaner; Qasem M. A. Abdallah; Guy J. Clarkson; David J. Fox; Pratik Gurnani; Suzanne E. Howson; Roger M. Phillips; David I. Roper; Daniel Simpson; Peter Scott


Chemical Science | 2016

Anticancer metallohelices: nanomolar potency and high selectivity

Rebecca A. Kaner; Simon J. Allison; Alan D. Faulkner; Roger M. Phillips; David I. Roper; Samantha L. Shepherd; Daniel Simpson; Nicholas R. Waterfield; Peter Scott


Archive | 2015

Dataset to support article : 'Anticancer metallohelices : nanomolar potency and high selectivity'

Rebecca A. Kaner; Simon A. Allison; Alan D. Faulkner; Daniel Simpson; Nicholas R. Waterfield; Roger M. Phillips; David I. Roper; Samantha L. Shepherd; Peter Scott


Archive | 2015

Data for Anticancer metallohelices : nanomolar potency and high selectivity

Rebecca A. Kaner; Simon A. Allison; Alan D. Faulkner; Daniel Simpson; Nicholas R. Waterfield; Roger M. Phillips; David I. Roper; Samantha L. Shepherd; Peter Scott


Archive | 2012

N-Oxidation of 5-hydroxy-2-methylpyridine

Rebecca A. Kaner


Archive | 2012

Oxidation of 6-(Hydroxymethyl)pyridin-3-ol

Rebecca A. Kaner


Archive | 2012

Acylation of an alcohol

Rebecca A. Kaner


Archive | 2012

Hydrolysis of the ester 6-{(Acetyloxy)methyl}pyridin-3-yl acetate

Rebecca A. Kaner

Collaboration


Dive into the Rebecca A. Kaner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roger M. Phillips

University of Huddersfield

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge